GH vs. PHG: Guardant Health vs. Koninklijke Philips Stock Comparison

Company Profile

Guardant Health (GH) and Koninklijke Philips (PHG) both fall under the Health Care Equipment & Services industry group, but GH is classified in Health Care Providers & Services while PHG is classified in Health Care Equipment & Supplies.

Guardant Health (GH) trades as ordinary local shares, while Koninklijke Philips (PHG) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Guardant Health (GH) has an aggressive beta of 1.69, indicating higher sensitivity to broad-market moves, while Koninklijke Philips (PHG) is defensive at 0.65 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: Koninklijke Philips (PHG) earns 8.61% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.

Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile Koninklijke Philips (PHG) reports 5.39%, ranking against industry peers normally.

Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Koninklijke Philips (PHG) reports 3.76%, ranking against industry peers normally.

Profitability Metrics

Growth

Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while Koninklijke Philips (PHG) at -1.04% is in the bottom quartile, showing a clear gap in revenue momentum.

Neither Guardant Health (GH) nor Koninklijke Philips (PHG) reports a EPS growth value for this period, so a direct comparison isn't possible.

Growth Metrics

Financial Strength

Guardant Health (GH) at 3.60 keeps current ratio within its industry’s typical mid-range, while Koninklijke Philips (PHG) at 1.33 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for PHG.

Only one side’s leverage can be read here: Koninklijke Philips (PHG) carries debt-to-equity ratio of 0.70 against its industry range, while Guardant Health (GH) reports no figure this period.

Financial Strength Metrics

Dividends

Neither Guardant Health (GH) nor Koninklijke Philips (PHG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Koninklijke Philips (PHG) reports payout ratio above 100% at 211.79%, meaning dividends exceeded current-period earnings; Guardant Health (GH) pays no dividend (payout 0.00%).

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Koninklijke Philips (PHG) trades at 63.23 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.

Koninklijke Philips (PHG) at 1.67 prices around its industry’s typical P/S ratio, while Guardant Health (GH) at 15.96 clears its benchmark range — GH looks notably rich on sales.

Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Koninklijke Philips (PHG) reports 2.28, ranking against industry peers normally.

Valuation Metrics